FAQ: CLL Society's 2025 Research Program Awards and Their Impact on CLL/SLL Care

Summary
What is the CLL Society’s Research Program?
The CLL Society’s Research Program funds novel projects aimed at improving outcomes and quality of life for those living with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), through groundbreaking research, advocacy, and support.
Who are the 2025 Research Program recipients?
The 2025 recipients are Dr. Nancy Musoke for the Integrative Medicine Award, Dr. Matthew S. Davids for the Clinical Scholar Award, and Dr. Quinlan Sievers for the Young Investigator Award, each recognized for their innovative research in CLL/SLL care.
What is Dr. Nancy Musoke’s research project about?
Dr. Musoke’s project explores the effects of curcumin supplementation and increased physical activity on immune health, quality of life, and disease progression in CLL/SLL patients during the ‘watch-and-wait’ phase.
What does Dr. Matthew S. Davids’ project focus on?
Dr. Davids’ project investigates new non-chemotherapy treatment approaches for Richter’s transformation, a rare and aggressive progression of CLL, using glofitamab alone and in combination with other novel agents.
What is the goal of Dr. Quinlan Sievers’ research?
Dr. Sievers’ research aims to discover and overcome mechanisms of resistance to BTK inhibitors, a promising new class of therapy for CLL/SLL, to guide more durable and personalized treatment options.
Why are these awards significant?
These awards support innovative research that addresses critical gaps in CLL/SLL care, potentially leading to improved treatments, better quality of life, and personalized therapy options for patients.
How are the Research Program awards funded?
The awards are made possible through generous community donations and matching grants, such as the one from Vigyan Singhal for the Integrative Medicine Award.
Where can I find more information about the CLL Society and its Research Program?
More information can be found on the CLL Society’s official website at https://cllsociety.org/.

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at citybiz
Article Control ID: 112679